The U.S. Food and Drug Administration (FDA) has sent a warning letter to a Taiwan seafood processing company, advising them that their company’s hazard analysis and critical control points (HACCP) plan for seafood products fails to comply with U.S. requirements.
The September 30, 2016 warning letter to Shin Ho Sing Ocean Enterprises Co, Ltd. in Kaohsiung City, Taiwan follows an examination of the company’s HACCP plan obtain during an inspection of Hadson (Toko) Trading Co., Inc. Located in Maspeth, New York, Hadson imports a cooked and frozen variety of a type of fish known as saury from Shin Ho Sing.
According to the FDA’s warning letter, Shin Ho Sing’s HACCP plan deviates in a number of significant ways from U.S. law and FDA regulations for seafood HACCP plans. Specific deviations include failure to list critical control points for unrefrigerated processing, insufficient critical limit cooking temperatures, and inadequate corrective actions at several different critical control points.
The FDA has requested a prompt response from the company as to the steps it has taken to address the deficiencies noted in its warning letter. Failure to do so could result in the company’s seafood products being detained without physical examination (DWPE) at U.S. ports of entry.
The complete text of the FDA’s warning letter is accessible here.